Tesamorelin earned its approval through two Phase 3, multicenter, randomized, double-blind, placebo-controlled trials (LIPO-010 and LIPO-011) enrolling 816 patients
It can be highly effective for weight loss and management of obesity-induced complications, especially when surgeons use minimally invasive procedures
However, coverage for GLP-1 drugs is expanding, and Medicare and Medicaid could soon begin to cover GLP-1 drugs for weight loss management
These include: itching and swelling of the face, throat, or tongue breathing difficulties severe dizziness sudden vision changes slurred speech
Nutritional counseling and accountability sessions support sustainable change, ensuring that youre not just losing weightbut doing so in a way that fits your life for the long haul
L-carnitine is often sold to us as a "fat-burning" supplement because it helps us metabolise fatty acids